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ABSTRACT: Nicotine has ameliorating effects on sensorimotor gating in schizophrenia. 
We have shown that nicotine ameliorated disruption of prepulse inhibition (PPI) via the 
α7 nicotinic acetylcholine receptor (nAChR) in Wister rats. The 5-HT3 receptor antagonist 
tropisetron was recently found to be an α7 nAChR partial agonist. We initially investigated the 
effects of tropisetron on disruption of PPI induced by phencyclidine (PCP) or apomorphine. 
Tropisetron had no effects on the disruption of PPI induced PCP, but ameliorated the 
disruption by apomorphine. The ameliorating effect of tropisetron was antagonized by 
methyllicaconitine, a partially selective α7 nAChR antagonist. Next, to find the action site 
of tropisetron, we examined c-Fos protein expression in the nucleus accumbens (NAc), 
dorsolateral striatum (DLst) and ventral tegmental area (VTA). Tropisetron alone did not 
change the number of c-Fos-positive cells, whereas apomorphine increased the number of 
positive cells in the NAc and DLst. Tropisetron administration followed by apomorphine 
administration decreased the number of positive cells in the VTA compared with the 
apomorphine alone group. These results suggested that tropisetron has an ameliorating effect 
on the sensonimotor gating deficits via the α7 nAChR, and that one possible site of its action 
is the VTA.
抄録　近年、セロトニン 5-HT3 受容体アンタゴニスト tropisetron が、α7型ニコチン
性アセチルコリン受容体 (nAChR) の部分アゴニストでもあることが明らかとなって
いる。本研究では、Wistar 系ラットを用いて tropisetron の抗精神病薬としての可能
性を探索した。Tropisetron は ドパミン受容体アゴニストである apomorphine による
prepulse inhibition (PPI) 障害を改善し、その改善作用は α7型 nAChR アンタゴニスト
methyllycaconitine により拮抗された。しかし、 N-methyl- D-aspartate 型グルタミン酸 
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(NMDA) 受容体アンタゴニストの phencyclidine により惹起される PPI 障害に対 しては
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